Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP as a Target to Lower CVD Risk: Suspension of Disbelief?

Affiliations

¹ From Department of Vascular Medicine (G.K.H.) and Department of Cardiology (S.M.B.), Academic Medical Center, Amsterdam, The Netherlands; and Department of Primary Care and Public Health, School of Public Health, Imperial College, London, United Kingdom (K.K.R.). g.k.hovingh@amc.uva.nl.
² From Department of Vascular Medicine (G.K.H.) and Department of Cardiology (S.M.B.), Academic Medical Center, Amsterdam, The Netherlands; and Department of Primary Care and Public Health, School of Public Health, Imperial College, London, United Kingdom (K.K.R.).

G Kees Hovingh et al. Circulation. 2015.

. 2015 Aug 4;132(5):433-40.

doi: 10.1161/CIRCULATIONAHA.115.014026.

¹ From Department of Vascular Medicine (G.K.H.) and Department of Cardiology (S.M.B.), Academic Medical Center, Amsterdam, The Netherlands; and Department of Primary Care and Public Health, School of Public Health, Imperial College, London, United Kingdom (K.K.R.). g.k.hovingh@amc.uva.nl.
² From Department of Vascular Medicine (G.K.H.) and Department of Cardiology (S.M.B.), Academic Medical Center, Amsterdam, The Netherlands; and Department of Primary Care and Public Health, School of Public Health, Imperial College, London, United Kingdom (K.K.R.).

No abstract available

Publication types